News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,747 Results
Type
Article (6445)
Company Profile (48)
Press Release (219254)
Multimedia
Podcasts (4)
Webinars (5)
Section
Business (63881)
Career Advice (343)
Deals (12715)
Drug Delivery (26)
Drug Development (18610)
Employer Resources (28)
FDA (6472)
Job Trends (5186)
News (104045)
Policy (8639)
Tag
Academia (675)
Accelerated approval (1)
Adcomms (1)
Allergies (37)
Alliances (21574)
ALS (31)
Alzheimer's disease (406)
Antibody-drug conjugate (ADC) (18)
Approvals (6492)
Artificial intelligence (164)
Autoimmune disease (6)
Automation (15)
Bankruptcy (82)
Best Places to Work (4730)
BIOSECURE Act (3)
Biosimilars (42)
Biotechnology (36)
Bladder cancer (27)
Brain cancer (9)
Breast cancer (80)
Cancer (577)
Cardiovascular disease (45)
Career advice (299)
Career pathing (9)
CAR-T (22)
Cell therapy (95)
Cervical cancer (5)
Clinical research (15569)
Collaboration (438)
Compensation (82)
Complete response letters (9)
COVID-19 (832)
CRISPR (19)
C-suite (79)
Cystic fibrosis (23)
Data (668)
Decentralized trials (2)
Denatured (2)
Depression (17)
Diabetes (86)
Diagnostics (3171)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (44)
Drug pricing (23)
Drug shortages (7)
Duchenne muscular dystrophy (9)
Earnings (22296)
Editorial (6)
Employer resources (26)
Events (28829)
Executive appointments (281)
FDA (7022)
Frontotemporal dementia (1)
Funding (310)
Gene editing (33)
Generative AI (12)
Gene therapy (74)
GLP-1 (235)
Government (951)
Grass and pollen (3)
Guidances (24)
Healthcare (6799)
Huntington's disease (4)
IgA nephropathy (5)
Immunology and inflammation (19)
Indications (12)
Infectious disease (887)
Inflammatory bowel disease (42)
Inflation Reduction Act (1)
Influenza (20)
Intellectual property (46)
Interviews (57)
IPO (5347)
IRA (5)
Job creations (652)
Job search strategy (237)
Kidney cancer (2)
Labor market (3)
Layoffs (67)
Leadership (7)
Legal (1415)
Liver cancer (13)
Lung cancer (89)
Lymphoma (32)
Machine learning (3)
Management (13)
Manufacturing (164)
MASH (11)
Medical device (7160)
Medtech (7163)
Mergers & acquisitions (7670)
Metabolic disorders (202)
Multiple sclerosis (22)
NASH (2)
Neurodegenerative disease (26)
Neuropsychiatric disorders (3)
Neuroscience (574)
NextGen: Class of 2025 (2606)
Non-profit (1102)
Now hiring (6)
Obesity (111)
Opinion (56)
Ovarian cancer (13)
Pain (49)
Pancreatic cancer (18)
Parkinson's disease (44)
Partnered (11)
Patents (109)
Patient recruitment (38)
Peanut (17)
People (16579)
Pharmaceutical (11)
Pharmacy benefit managers (4)
Phase I (4161)
Phase II (6516)
Phase III (6036)
Pipeline (412)
Policy (17)
Postmarket research (621)
Preclinical (1606)
Press Release (22)
Prostate cancer (24)
Psychedelics (9)
Radiopharmaceuticals (73)
Rare diseases (113)
Real estate (1974)
Recruiting (6)
Regulatory (6939)
Reports (14)
Research institute (685)
Resumes & cover letters (51)
Rett syndrome (3)
RNA editing (2)
RSV (7)
Schizophrenia (22)
Series A (50)
Series B (38)
Service/supplier (7)
Sickle cell disease (15)
Special edition (2)
Spinal muscular atrophy (24)
Sponsored (17)
Startups (971)
State (2)
Stomach cancer (1)
Supply chain (38)
Tariffs (2)
The Weekly (2)
Vaccines (207)
Venture capitalists (4)
Weight loss (71)
Women's health (16)
Worklife (4)
Date
Last 7 days (272)
Last 30 days (874)
Last 365 days (11853)
2025 (4013)
2024 (12684)
2023 (14292)
2022 (20541)
2021 (22294)
2020 (21939)
2019 (18878)
2018 (13797)
2017 (11657)
2016 (10740)
2015 (12225)
2014 (8728)
2013 (7205)
2012 (7712)
2011 (7533)
2010 (6393)
Location
Africa (171)
Alabama (25)
Alaska (2)
Arizona (66)
Arkansas (5)
Asia (12321)
Australia (1679)
California (1854)
Canada (844)
China (153)
Colorado (136)
Connecticut (109)
Delaware (67)
Europe (30970)
Florida (363)
Georgia (122)
Idaho (42)
Illinois (258)
India (15)
Indiana (194)
Iowa (5)
Japan (67)
Kansas (54)
Kentucky (7)
Louisiana (4)
Maine (26)
Maryland (310)
Massachusetts (1223)
Michigan (125)
Minnesota (240)
Mississippi (2)
Missouri (52)
Montana (20)
Nebraska (12)
Nevada (24)
New Hampshire (40)
New Jersey (706)
New Mexico (17)
New York (500)
North Carolina (474)
North Dakota (7)
Northern California (734)
Ohio (99)
Oklahoma (6)
Oregon (15)
Pennsylvania (460)
Puerto Rico (9)
Rhode Island (16)
South America (325)
South Carolina (17)
South Dakota (1)
Southern California (698)
Tennessee (44)
Texas (291)
United States (8120)
Utah (58)
Virginia (62)
Washington D.C. (14)
Washington State (132)
West Virginia (2)
Wisconsin (50)
225,747 Results for "formulated solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation
April 14, 2025
·
7 min read
Press Releases
Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
April 15, 2025
·
3 min read
Press Releases
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
April 8, 2025
·
1 min read
Press Releases
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
April 2, 2025
·
2 min read
Press Releases
Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities
April 23, 2025
·
5 min read
Press Releases
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
April 28, 2025
·
4 min read
Press Releases
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
April 28, 2025
·
2 min read
Business
Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine
Revive Therapeutics Ltd. is pleased to announce that it has signed a collaboration agreement with Attwill Medical Solutions LP (“AMS”) for the clinical and commercial development of the Company’s next-generation lyophilized formulation of Bucillamine.
December 18, 2023
·
4 min read
Press Releases
BioNxt Solutions Prepares for Human Bioequivalence Study For MS
April 23, 2025
·
3 min read
Press Releases
Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
March 26, 2025
·
6 min read
1 of 22,575
Next
